A designer bleomycin with significantly improved DNA cleavage activity
Huang Sheng-Xiong ; Feng Zhiyang ; Wang Liyan ; Galm Ute ; Wendt-Pienkowski Evelyn ; Yang Dong ; Tao Meifeng ; Coughlin Jane M ; Duan Yanwen ; Shen Ben*
2012
发表期刊J. Am. Chem. Soc
期号134页码:13501-13509
摘要The bleomycins (BLMs) are used clinically in combination with a number of other agents for the treatment of several types of tumors, and the BLM, etoposide, and cisplatin treatment regimen cures 90−95% of metastatic testicular cancer patients. BLM-induced pneumonitis is the most feared, doselimiting side effect of BLM in chemotherapy, which can progress into lung fibrosis and affect up to 46% of the total patient population. There have been continued efforts to develop new BLM analogues in the search for anticancer drugs with better clinical efficacy and lower lung toxicity. We have previously cloned and characterized the biosynthetic gene clusters for BLMs from Streptomyces verticillus ATCC15003, tallysomycins from Streptoalloteichus hindustanus E465-94 ATCC31158, and zorbamycin (ZBM) from Streptomyces f lavoviridis SB9001. Comparative analysis of the three biosynthetic machineries provided the molecular basis for the formulation of hypotheses to engineer novel analogues. We now report engineered production of three new analogues, 6′-hydroxy-ZBM, BLM Z, and 6′-deoxy-BLM Z and the evaluation of their DNA cleavage activities as a measurement for their potential anticancer activity. Our findings unveiled: (i) the disaccharide moiety plays an important role in the DNA cleavage activity of BLMs and ZBMs, (ii) the ZBM disaccharide significantly enhances the potency of BLM, and (iii) 6′-deoxy-BLM Z represents the most potent BLM analogue known to date. The fact that 6′-deoxy-BLM Z can be produced in reasonable quantities by microbial fermentation should greatly facilitate follow-up mechanistic and preclinical studies to
potentially advance this analogue into a clinical drug.
收录类别SCI
文献类型期刊论文
条目标识符http://ir.kib.ac.cn/handle/151853/18016
专题植物化学与西部植物资源持续利用国家重点实验室
推荐引用方式
GB/T 7714
Huang Sheng-Xiong,Feng Zhiyang,Wang Liyan,et al. A designer bleomycin with significantly improved DNA cleavage activity[J]. J. Am. Chem. Soc,2012(134):13501-13509.
APA Huang Sheng-Xiong.,Feng Zhiyang.,Wang Liyan.,Galm Ute.,Wendt-Pienkowski Evelyn.,...&Shen Ben*.(2012).A designer bleomycin with significantly improved DNA cleavage activity.J. Am. Chem. Soc(134),13501-13509.
MLA Huang Sheng-Xiong,et al."A designer bleomycin with significantly improved DNA cleavage activity".J. Am. Chem. Soc .134(2012):13501-13509.
条目包含的文件
文件名称/大小 文献类型 版本类型 开放类型 使用许可
A Designer Bleomycin(3304KB) 开放获取CC BY-NC-SA请求全文
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Huang Sheng-Xiong]的文章
[Feng Zhiyang]的文章
[Wang Liyan]的文章
百度学术
百度学术中相似的文章
[Huang Sheng-Xiong]的文章
[Feng Zhiyang]的文章
[Wang Liyan]的文章
必应学术
必应学术中相似的文章
[Huang Sheng-Xiong]的文章
[Feng Zhiyang]的文章
[Wang Liyan]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。